Ottenburg, Belgium

Klaas DeCanniere


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaas DeCanniere: Innovator in Nucleic Acid Isolation

Introduction

Klaas DeCanniere is a notable inventor based in Ottenburg, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid isolation. His innovative work has led to the development of methods that enhance the efficiency and automation of biological sample processing.

Latest Patents

Klaas DeCanniere holds a patent for an "Automatable method for nucleic acid isolation." This invention relates to a highly automatable method for the isolation and purification of nucleic acids from biological samples. It is particularly suitable for nucleic acids shorter than 250 base pairs and can be performed without a proteolytic pre-digestion step in an automated system, preferably a cartridge-based system. Additionally, the invention provides automated nucleic acid detection methods based on the isolation and purification method, along with buffers and kits for performing these methods. He has 1 patent to his name.

Career Highlights

Klaas DeCanniere is currently associated with Biocartis NV, a company that focuses on innovative molecular diagnostics. His work at Biocartis has allowed him to contribute to advancements in the field of automated nucleic acid testing, which is crucial for various applications in medical diagnostics and research.

Collaborations

Klaas collaborates with Geert Meersseman, who is also involved in the development of innovative solutions in the biotechnology sector. Their partnership exemplifies the collaborative spirit that drives innovation in the field.

Conclusion

Klaas DeCanniere's contributions to nucleic acid isolation and purification represent a significant advancement in biotechnology. His innovative methods and collaboration with industry professionals continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…